{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:59:19Z","timestamp":1790949559506,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002999","name":"Ministerie van Volksgezondheid, Welzijn en Sport","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002999","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jtha.2022.11.040","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T10:24:20Z","timestamp":1674642260000},"page":"850-861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Little discrepancy between one-stage and chromogenic factor VIII (FVIII)\/IX assays in a large international cohort of persons with nonsevere hemophilia A and B"],"prefix":"10.1016","volume":"21","author":[{"given":"Anne-Fleur","family":"Zwagemaker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne R.","family":"Kloosterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha C.","family":"Gouw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Boyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Brons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjon H.","family":"Cnossen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Eikenboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Hay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rutger C.C.","family":"Hengeveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline A.M.","family":"Klopper-Tol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke J.H. A.","family":"Kruip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta Laros-van","family":"Gorkom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Male","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurens","family":"Nieuwenhuizen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Fijnvandraat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel","family":"Coppens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2022.11.040_bib1","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1111\/jth.12672","article-title":"Definitions in hemophilia: communication from the SSC of the ISTH","volume":"12","author":"Blanchette","year":"2014","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.11.040_bib2","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/hae.12639","article-title":"Current laboratory practices in the diagnosis and management of haemophilia: a global assessment","volume":"21","author":"Kitchen","year":"2015","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2022.11.040_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ejh.13339","article-title":"Clinical utility and impact of the use of the chromogenic vs one-stage factor activity assays in haemophilia A and B","volume":"104","author":"Marlar","year":"2020","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jtha.2022.11.040_bib4","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/jth.13253","article-title":"A\u00a0computer-based model to assess costs associated with the use of factor VIII and factor IX one-stage and chromogenic activity assays","volume":"14","author":"Kitchen","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.11.040_bib5","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/jth.13215","article-title":"A\u00a0critical appraisal of one-stage and chromogenic assays of factor VIII activity","volume":"14","author":"Peyvandi","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.11.040_bib6","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/ajcp\/aqaa024","article-title":"Discrepant hemophilia A: an underdiagnosed disease entity","volume":"154","author":"Al-Huniti","year":"2020","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jtha.2022.11.040_bib7","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1160\/TH13-08-0690","article-title":"Haemophilia A mutations in patients with non-severe phenotype associated with a discrepancy between one-stage and chromogenic factor VIII activity assays","volume":"111","author":"Pavlova","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.11.040_bib8","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.3324\/haematol.2013.088088","article-title":"Specific and global coagulation assays in the diagnosis of discrepant mild hemophilia A","volume":"98","author":"Bowyer","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2022.11.040_bib9","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1111\/jth.14315","article-title":"The definition, diagnosis and management of mild hemophilia A: communication from the SSC of the ISTH","volume":"16","author":"Makris","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.11.040_bib10","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/hae.13219","article-title":"Discrepancies between the one-stage clotting assay and the chromogenic assay in haemophilia B","volume":"23","author":"Kihlberg","year":"2017","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2022.11.040_bib11","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/j.1365-2516.2008.01781.x","article-title":"One-stage and chromogenic FVIII:C assay discrepancy in mild haemophilia A and the relationship with the mutation and bleeding phenotype","volume":"14","author":"Cid","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2022.11.040_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hae.14046","article-title":"WFH guidelines for the management of hemophilia","volume":"26","author":"Srivastava","year":"2020","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2022.11.040_bib13","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/hae.14106","article-title":"The one-stage assay or chromogenic assay to monitor baseline factor VIII levels and desmopressin effect in non-severe haemophilia A: superiority or non-inferiority?","volume":"26","author":"Schutte","year":"2020","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2022.11.040_bib14","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing agreement between two methods of clinical measurement","volume":"1","author":"Bland","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2022.11.040_bib15","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1182\/bloodadvances.2022007620","article-title":"The bleeding phenotype in people with non-severe hemophilia","volume":"6","author":"Kloosterman","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2022.11.040_bib16","article-title":"One-stage versus chromogenic factor IX activity in haemophilia B [abstract]","volume":"4","author":"Trudesson","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.11.040_bib17","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1055\/s-0033-1334863","article-title":"Diagnostic testing for mild hemophilia A in patients with discrepant one-stage, two-stage, and chromogenic factor VIII:C assays","volume":"39","author":"Duncan","year":"2013","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2022.11.040_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-0040-1715443","article-title":"Genetics and hemostatic potential in persons with mild to moderate hemophilia A with a discrepancy between one-stage and chromogenic FVIII assays","volume":"121","author":"Stralfors","year":"2021","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.11.040_bib19","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1538-7836.2010.04174.x","article-title":"Prevalence, biological phenotype and genotype in moderate\/mild hemophilia A with discrepancy between one-stage and chromogenic factor VIII activity","volume":"9","author":"Trossaert","year":"2011","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.11.040_bib20","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/hae.12381","article-title":"Diagnosis and management challenges in patients with mild haemophilia A and discrepant FVIII measurements","volume":"20","author":"Trossaert","year":"2014","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2022.11.040_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2021.103194","article-title":"Genetic analysis of non-severe hemophilia A phenotype with A discrepancy between one-stage and chromogenic factor VIII activity assays","volume":"60","author":"Valikhani","year":"2021","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.jtha.2022.11.040_bib22","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/ijlh.13335","article-title":"Impact of variation in reagent combinations for one-stage clotting assay on assay discrepancy in nonsevere haemophilia A","volume":"43","author":"Suzuki","year":"2021","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jtha.2022.11.040_bib23","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1046\/j.1365-2141.2000.02021.x","article-title":"Assay discrepancy in mild haemophilia A due to a factor VIII missense mutation (Asn694Ile) in a large Danish family","volume":"109","author":"Schwaab","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2022.11.040_bib24","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1046\/j.1365-2141.1999.01460.x","article-title":"Diagnostic importance of the two-stage factor VIII:C assay demonstrated by a case of mild haemophilia associated with His1954\u2013>Leu substitution in the factor VIII A3 domain","volume":"105","author":"Keeling","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2022.11.040_bib25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-2516.2005.01069.x","article-title":"Mutation analysis in 51 patients with haemophilia A: report of 10 novel mutations and correlations between genotype and clinical phenotype","volume":"11","author":"Hill","year":"2005","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2022.11.040_bib26","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1365-2516.2007.01557.x","article-title":"Tyr346\u2013>Cys mutation results in factor VIII:C assay discrepancy and a normal bleeding phenotype - is this mild haemophilia A?","volume":"14","author":"Lyall","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2022.11.040_bib27","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1046\/j.1365-2141.2002.03617.x","article-title":"A\u00a0Tyr346\u2013>Cys substitution in the interdomain acidic region a1 of factor VIII in an individual with factor VIII:C assay discrepancy","volume":"118","author":"Mumford","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2022.11.040_bib28","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1055\/s-0033-1356573","article-title":"Problems and solutions in laboratory testing for hemophilia","volume":"39","author":"Favaloro","year":"2013","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2022.11.040_bib29","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/hae.13643","article-title":"Analytical variation in factor VIII one-stage and chromogenic assays: experiences from the ECAT external quality assessment programme","volume":"25","author":"van Moort","year":"2019","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2022.11.040_bib30","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2516.2008.01896.x","article-title":"Influence of source of phospholipids for APTT-based factor IX assays and potential consequences for the diagnosis of mild haemophilia B","volume":"15","author":"Pouplard","year":"2009","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2022.11.040_bib31","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1365-2141.2006.06402.x","article-title":"In\u00a0vitro kinetics of factor VIII activity in patients with mild haemophilia A and a discrepancy between one-stage and two-stage factor VIII assay results","volume":"136","author":"Rodgers","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2022.11.040_bib32","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/jth.13581","article-title":"Variation in baseline factor VIII concentration in a retrospective cohort of mild\/moderate hemophilia A patients carrying identical F8 mutations","volume":"15","author":"Loomans","year":"2017","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.11.040_bib33","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/ijlh.12877","article-title":"Advantages, disadvantages and optimization of one-stage and chromogenic factor activity assays in haemophilia A and B","volume":"40","author":"Adcock","year":"2018","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jtha.2022.11.040_bib34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2516.2010.02295.x","article-title":"New developments in laboratory diagnosis and monitoring","volume":"16","author":"Kitchen","year":"2010","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2022.11.040_bib35","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/ejh.12500","article-title":"One-stage vs. chromogenic assays in haemophilia A","volume":"94","author":"Potgieter","year":"2015","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jtha.2022.11.040_bib36","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/hae.13520","article-title":"Role of chromogenic assays in haemophilia A and B diagnosis","volume":"24","author":"Bowyer","year":"2018","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2022.11.040_bib37","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1365-2141.2011.08688.x","article-title":"p.Tyr365Cys change in factor VIII: haemophilia A, but not as we know it","volume":"154","author":"Bowyer","year":"2011","journal-title":"Br J Haematol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622078217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622078217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:36:07Z","timestamp":1761536167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622078217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S1538783622078217"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2022.11.040","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Little discrepancy between one-stage and chromogenic factor VIII (FVIII)\/IX assays in a large international cohort of persons with nonsevere hemophilia A and B","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2022.11.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}